RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.
Shares of Vertex Pharmaceuticals rose after Journavx, the company's oral non-opioid pain medication, received Food and Drug Administration approval. The Boston company's stock rose 4.3%, to $457.25, ...
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
Robert F. Kennedy Jr.'s second confirmation hearing highlights vaccine skepticism, bipartisan concerns, and his plans as ...
The HHS Secretary nominee confused Medicare and Medicaid programs, though he would be responsible for them if confirmed. We ...
Robert F. Kennedy Jr. incorrectly said that Medicaid was fully funded by the federal government and that Medicare is a ...
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
President Donald Trump, in signing dozens of executive orders on Monday, rescinded an effort by former President Joe Biden to lower drug costs by directing Medicare and Medicaid to test models that ...